Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 4/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.52 |
| ▸ | BACE1 | P56817 | 3/20 | 0.49 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.49 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29674783 | 0.95 | OPRM1 (0.53) | OPRM1OPRD1OPRK1BACE1OPRL1 | |
| SCHEMBL29436286 | 0.94 | OPRM1 (0.55) | OPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL31347335 | 0.93 | OPRL1 (0.56) | OPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL29375740 | 0.91 | BACE1 (0.56) | OPRM1OPRD1BACE1BACE2 | |
| SCHEMBL29375389 | 0.91 | BACE1 (0.56) | OPRM1OPRD1BACE1BACE2 | |
| SCHEMBL29378801 | 0.91 | BACE1 (0.54) | OPRM1OPRD1OPRK1BACE1BACE2 | |
| SCHEMBL30721650 | 0.90 | OPRM1 (0.55) | OPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL29375819 | 0.90 | OPRM1 (0.54) | OPRM1OPRD1OPRK1BACE1OPRL1 | |
| SCHEMBL31347347 | 0.88 | GLP1R (0.51) | OPRM1OPRD1OPRK1 | |
| SCHEMBL29695617 | 0.86 | OPRM1 (0.63) | OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11713344-B2 | Acylated oxyntomodulin peptide analog | DONG-A ST CO., LTD. (KR) | 2023-08-01 | — | — | US | claimed |
| EP-4079757-A1 | ACYLATED OXYNTOMODULIN PEPTIDE ANALOG | Dong-A St Co., Ltd. (KR) | 2022-10-26 | — | — | EP | claimed |
| US-20220119473-A1 | ACYLATED OXYNTOMODULIN PEPTIDE ANALOG | DONG-A ST CO., LTD. (KR) | 2022-04-21 | — | — | US | claimed |
| US-11713344-B2 | Acylated oxyntomodulin peptide analog | DONG-A ST CO., LTD. (KR) | 2023-08-01 | — | — | US | disclosed |
| EP-4079757-A1 | ACYLATED OXYNTOMODULIN PEPTIDE ANALOG | Dong-A St Co., Ltd. (KR) | 2022-10-26 | — | — | EP | disclosed |
| US-20220119473-A1 | ACYLATED OXYNTOMODULIN PEPTIDE ANALOG | DONG-A ST CO., LTD. (KR) | 2022-04-21 | — | — | US | disclosed |
| US-11236142-B2 | Acylated oxyntomodulin peptide analog | DONG-A ST CO., LTD. (KR) | 2022-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11713344-B2 | Acylated oxyntomodulin peptide analog | GLP1R, GIPR, GPR119 | OPRM1 76/4885OPRD1 88/4885OPRK1 156/4885 |
| US-20220119473-A1 | ACYLATED OXYNTOMODULIN PEPTIDE ANALOG | GLP1R, GIPR, GPR119 | OPRM1 76/4885OPRD1 88/4885OPRK1 156/4885 |
| US-11236142-B2 | Acylated oxyntomodulin peptide analog | GLP1R, GIPR, GPR119 | OPRM1 79/4885OPRD1 112/4885OPRK1 162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.